FindMyRecallSubscribe
Class I: serious health riskTerminated

Pfizer Vancomycin Hydrochloride for Injection Recall

Vancomycin Hydrochloride for Injection, USP

Pfizer Inc. · New York, NY

Risk level
Class I
Reported by FDA
Dec 27, 2017
Recall ID
D-0123-2018
Check your lot numberHow we source this data

Summary

Pfizer recalled Vancomycin Hydrochloride for Injection starting Aug 30, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0123-2018 on Dec 27, 2017. Reason: Presence of Particulate Matter: glass particulate found in vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: glass particulate found in vial

Product description

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02

Lot numbers, UPCs & expiration codes

Lot: 632153A; Exp. 03/18

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0123-2018
Classification
Class I
Status
Terminated
Recall initiated
Aug 30, 2017
FDA report date
Dec 27, 2017
Quantity
102,500 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0123-2018, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
78000
Address
235 E 42nd St
Code information
Lot: 632153A; Exp. 03/18
Postal code
10017-5703
Report date
Dec 27, 2017
Product type
Drugs
Recall number
D-0123-2018
Classification
Class I
Recalling firm
Pfizer Inc.
Product quantity
102,500 vials
Termination date
Nov 8, 2018
Reason for recall
Presence of Particulate Matter: glass particulate found in vial
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Aug 30, 2017
Initial firm notification
Press Release
Center classification date
Dec 20, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0123-2018, published Dec 27, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls